Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Instagram Outage Disrupts Thousands of U.S. Users 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
San Jose, CA, July 12, 2017 -- Jan Marini Skin Research, Inc. (JMSR), a leading provider of professional skin care and aesthetic solutions, announced the promotion of John Connors to CEO in addition to his prior role as President of the company. Jan Marini will continue as Founder and Chairman of the Board.
|
|||
In addition to her key role in product research & development, Jan will strategically focus on expanding and developing key corporate accounts. “I didn’t grow JMSR by sitting behind a desk, and I believe my passion and real value lies in brand development and education.”
John Connors joined the company in late 2009 and has been instrumental to the significant rebranding of the company that has occurred since that time. JMSR has realigned virtually all key aspects of its Sales, Marketing & Clinical efforts with a designated goal of providing a dynamic range of clinically validated solutions to the aesthetic marketplace.
Jan Marini, Founder and Chairman of the Board, stated, “Over the last 7 plus years with Jan Marini, John has overhauled our strategic efforts in all key segments of our business. John’s leadership, vision and strategic skills make him the clear choice to take JMSR to the next level of success. I am excited for JMSR employees and our global customers with the appointment of John. I am additionally thrilled to take on my new expanded role, which will ultimately accelerate our objectives.”
Prior to his tenure with JMSR, John was with Cutera, Inc. for 10 years, where he held senior management roles which included EVP of Global Sales & Marketing.
John Connors, CEO and President of JMSR adds, “We have a tremendous opportunity to gain even further market success with these key corporate appointments. I am extremely confident that our talented team of employees will collectively take the JMSR brand to unchartered gains.”
About Jan Marini Skin Research, Inc.
A San Jose, CA, based company founded in 1994, Jan Marini Skin Research, Inc. is a recognized leader and innovator in the professionally dispensed skin care market segment. With multiple peer-reviewed published solutions and numerous industry innovations over the past 23 years, including the patented ingredient Thymosin Beta-4 and the first topical lipid-soluble Vitamin C product introduced to the market, JMSR’s two primary focuses are to provide innovated technologies that deliver proven measurable results and an unwavering commitment to the ongoing success of our customers.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/7937d609-7bbd-4635-8ee0-59fc1bf1f2fe
Kim Conley Jan Marini Skin Research 408-620-3611 [email protected]
